Regeneron

Health-Care Stocks: Growing Like Gangbusters
Motley Fool
Sat, 03/15/14 - 10:06 am
Regeneron
Sanofi
Gilead Sciences
Celgene
Allergan
With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool
Thu, 03/13/14 - 05:55 pm
FDA
Regeneron
Pfizer
Amgen
PCSK9 inhibitors
FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes
Sat, 03/8/14 - 10:31 am
PCSK9 inhibitors
Regeneron
Sanofi
hypercholesterolemia
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Yahoo/Reuters
Fri, 03/7/14 - 03:55 pm
Sanofi
FDA
Regeneron
alirocumab
PCSK9 inhibitors
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
Regeneron Chief Leonard Schleifer Becomes A Billionaire After 25 Year Search For New Drugs
Forbes
Wed, 02/26/14 - 11:05 am
Regeneron
Leonard Schleifer
executive pay
One Reason the Biotech Boom Won’t Turn to Bust
Barron's
Tue, 02/25/14 - 11:17 am
biotech
Biogen Idec
Regeneron
No Looking Back for Regeneron's Eylea
Yahoo/Zacks.com
Tue, 02/25/14 - 11:05 am
Regeneron
Eylea
BRVO
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
biotech
Celgene
Gilead Sciences
Biogen Idec
Amgen
Regeneron
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wed, 02/19/14 - 09:26 am
Regeneron
Eylea
Gilead Sciences
ledipasvir
Sovaldi
hepatitis C
Cangrelor
The Medicines Company
Breakout Week for Biotech? Comment Now Follow Comments
Forbes
Tue, 02/11/14 - 10:37 am
Seattle Genetics
Regeneron
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Tue, 02/11/14 - 08:52 am
Regeneron
Arcalyst
Eylea
Zaltrap
Is There Investment Upside In The Future Of Treating Diabetes?
Seeking Alpha
Mon, 02/10/14 - 08:43 am
diabetes
MannKind
Merck
Novo Nordisk
NeoStem
Regeneron
Can Biotech Dominate for a 4th Year in a Row?
Motley Fool
Mon, 02/3/14 - 09:35 am
biotech
IPOs
Amgen
Ariad Pharmaceuticals
Regeneron
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal
Yahoo/Zacks.com
Wed, 01/22/14 - 04:14 pm
Sarepta Therapeutics
Alnylam
Jazz Pharmaceuticals
Regeneron
Celgene
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
earnings
United Therapeutics
Celgene
Regeneron
Biogen Idec
Acorda Therapeutics
Amgen
Gilead Sciences
Illumina, Regeneron, Intuitive Q4 Results Impress
Investors.com
Wed, 01/15/14 - 08:58 am
earnings
Illumina
Regeneron
Intuitive Surgical
Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Mon, 01/6/14 - 04:34 pm
Cubist
Regeneron
Spectrum
Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus
Barron's
Mon, 01/6/14 - 11:44 am
biotech
Amgen
Regeneron
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals

Pages